Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218361 · ClinicalTrials.gov registry record
Effects of Post-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals
A clinical trial, sponsored by Wayne State University.
- Completed
- Registry status
- 16
- Enrollment target
NCT00218361: Completed study, sponsored by Wayne State University.
NCT00218361 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00218361 has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether knowledge of post-session hydromorphone (HYD) availability reduces drug seeking behavior in heroin dependent individuals.
Interventions
- DRUG Hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2005-08 |
What the finished NCT00218361 record still lists
NCT00218361 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Hydromorphone is the first listed.
NCT00218361 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00218361 about?
NCT00218361 is a clinical study titled "Effects of Post-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals". The purpose of this study is to determine whether knowledge of post-session hydromorphone (HYD) availability reduces drug seeking behavior in heroin dependent individuals.
What is the current status of trial NCT00218361?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2005-08.
What interventions are being tested in trial NCT00218361?
The interventions under investigation include: Hydromorphone (DRUG).
Who is sponsoring clinical trial NCT00218361?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia